As of December 2024, Immix Biopharma Common Stock has a market cap of $44.11M. This makes Immix Biopharma Common Stock the world's 24389th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $54.44M | -60.40% |
2023 | $137.48M | 202.18% |
2022 | $45.50M | -35.67% |
2021 | $70.73M | - |